HDFC Pharma and Healthcare Fund Regular Growth
- Rating N.A.
- Plan
- 5D
- 1M
- 6M
- 1Y
- 5Y
- MAX
Key Metrics
- AUM (in Cr)1577.12
- CAGR 25.99%
- Exit Load1.00%
- Expense ratio2.14%
- CategoryEquity
- Min Investment100
- Min SIP100
- Launch Date2023-10-04
Asset Allocation
Holdings As On - 13 February 2025
- Name
- Value (Cr)
- Holding %
- Sun Pharmaceutical Industries
- 208.47
- 13.22%
- Cipla
- 124.52
- 7.89%
- Divis Laboratories
- 113.20
- 7.18%
- Lupin
- 97.32
- 6.17%
- Aster DM Healthcare
- 61.42
- 3.89%
- IPCA Laboratories
- 60.12
- 3.81%
- Gland Pharma
- 59.66
- 3.78%
- Krishna Instit Of Medical Scienc
- 55.48
- 3.52%
- Treps - Tri-Party Repo
- 54.00
- 3.42%
- Glenmark Pharmaceuticals
- 51.76
- 3.28%